A one-time COPD treatment to preserve lung health.
New clinical data suggests that dNerva lung denervation improves lung function, reduces exacerbations and decreases breathlessness for people with COPD who have lung hyperinflation and low emphysema.
Unmet Need for Single-Treatment Option in COPD
Lung Denervation Impact in COPD
Treatment Goal:
Disrupt pulmonary nerve input to the lung to alter lung physiology and reduce the clinical consequences of neural hyperactivity.
- Preserve lung function
- Improve Dyspnea (breathlessness)
- Reduce COPD Exacerbations
Before
After
Whole lung, sustained bronchodilation 31-33
Decreased airway hyper-responsiveness 34-36
Decreased mucus hypersecretion 37-40
Current Therapies Aren’t Always Enough
A New Treatment Concept in COPD.
For some patients, inhaled therapies alone may not provide the relief they need, and many prefer to avoid adding another costly medication.10,11 Lung denervation offers a one-time procedure that has been shown in multiple clinical trials to deliver lasting improvements in symptoms and COPD outcomes.
dNerva Lung Denervation System
The dNerva Lung Denervation System is a catheter-based system used to complete a one-time, out-patient, bronchoscopic procedure to disrupt nerve input to and from the lungs to reduce the clinical consequences of neural hyperactivity.